(See Prognosis and Treatment.) Patients with metastatic bone disease are generally treated with surgery or radiation therapy (RT). Radiation therapy RT remains a primary therapeutic modality for the treatment of spinal metastasis, because nearly 95% of patients who are ambulatory at the start of ...
The prognosis of metastatic bone disease is dependent on the primary site, with breast and prostate cancers associated with a survival measured in years compared with lung cancer, where the average survival is only a matter of months. Additionally, the presence of ...
Contrary to the belief that the prognosis of patients with metastatic bone disease (MBD) as bad, the literature showed good quality life span to these group of patients. Survival up to 10 yrs in patients with exclusive bone secondaries has been reported. The question whether this result can ...
Due to the associated bone pain, pathological fractures, and hypercalcemia, metastases to bone can considerably influence the course and prognosis of a neoplastic disease. As metastases to bone are the expression of hematogenous dissemination the detection of osseous metastases means that curative therapy...
The prognosis of metastatic bone disease is dependent on the primary site, with breast and prostate cancers associated with a survival measured in years compared with lung cancer, where the average survival is only a matter of months. Additionally, the presence of extraosseous disease and the ...
Bone is a common site of metastatic disease and the most frequent site of metastatic spread in patients with prostate cancer. Most patients with bone metas... Dolezal,Vizda,Odrazka - 《Urologia Internationalis》 被引量: 32发表: 2007年 Prognostic significance of changes in prostate-specific antige...
186Re-HEDP for Metastatic Bone Pain in Breast Cancer Patients Metastases in the skeleton are the most common of all bone neoplasms. The ultimate prognosis for patients suffering from bone metastases is poor. Therapy such as hormonal manipulation (for carcinomas of the breast and prostate) and cyt...
29 Based on the premise that the chance of survival is intimately linked to the anatomic extent (i.e., stage) of the disease, the TNM staging system stratifies cancer patients at diagnosis into four stages—with patients with Stage I disease having a much better prognosis as opposed to ...
Recently, it has been shown that bone metastatic cancer cells interact with the bone marrow microenvironment to survive and grow, and thus this microenvironment is referred to as the 'metastatic niche'. Once cancer cells spread to distant organs such as bone, the prognosis for the patient is ...
Patients with neuroblastoma younger than 12 months of age with a 4S pattern of disease (metastases limited to liver, skin, bone marrow) have better outcomes than infants with stage 4 disease. The new International Neuroblastoma Risk Group (INRG) staging system extends age to 18 months for the ...